SAN FRANCISCO, April 30 - Pharsight said today that it will supply software and support to Aventis Pharma for clinical development of four of the pharmaceutical company's drug candidates.
The multi-year deal caps a one year proof-of-product period where Pharsight applied modeling and simulation to an Aventis project, Pharsight said.
Aventis' software integrates its computer-based modeling of scientific, clinical, commercial, and financial information about a drug candidate to create models and simulations to help steer drug development.
Details of the agreement were not disclosed.
Pharsight said this was its largest customer deal to date.
For more information, click here.